CD30-directed CAR-T (CART30) Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD30-directed CAR-T (CART30) Therapy, covering 2016-01-28 to 2016-01-28. Get the full timeline:
Most recent: Clinical Trial Update: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas [Phase 1, Phase 2]